MORGAN STANLEY - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,252,243
-50.2%
986,017
+29.0%
0.00%
Q2 2023$2,515,242
-67.8%
764,511
-59.7%
0.00%
-100.0%
Q1 2023$7,803,382
-24.3%
1,898,633
+8.0%
0.00%0.0%
Q4 2022$10,301,799
-4.4%
1,757,986
+10.2%
0.00%0.0%
Q3 2022$10,779,000
+48.3%
1,594,574
+1.3%
0.00%0.0%
Q2 2022$7,270,000
-16.1%
1,573,704
-27.5%
0.00%0.0%
Q1 2022$8,663,000
+13.4%
2,171,373
+76.7%
0.00%0.0%
Q4 2021$7,642,000
+21.3%
1,228,607
+84.0%
0.00%0.0%
Q3 2021$6,299,000
+267.7%
667,889
+429.3%
0.00%
Q2 2021$1,713,000
+704.2%
126,177
+853.2%
0.00%
Q1 2021$213,000
-82.5%
13,237
-71.1%
0.00%
Q4 2020$1,217,000
+359.2%
45,738
+220.7%
0.00%
Q3 2020$265,000
-46.8%
14,264
-33.0%
0.00%
Q2 2020$498,000
+1678.6%
21,277
+336.3%
0.00%
Q1 2020$28,000
-93.6%
4,877
-93.6%
0.00%
Q4 2019$436,000
+1514.8%
76,048
+333.5%
0.00%
Q3 2019$27,000
-95.8%
17,542
-88.9%
0.00%
Q2 2019$639,000
+1675.0%
157,882
+2211.3%
0.00%
Q1 2019$36,000
-54.4%
6,831
-64.8%
0.00%
Q4 2018$79,000
-61.7%
19,406
-5.8%
0.00%
Q3 2018$206,000
-56.7%
20,595
-22.8%
0.00%
Q2 2018$476,000
+23.0%
26,673
+8.7%
0.00%
Q1 2018$387,000
+63.3%
24,548
+70.1%
0.00%
Q4 2017$237,000
-12.5%
14,429
-7.9%
0.00%
Q3 2017$271,00015,6650.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 8,663,673$40,026,0004.69%
Opaleye Management Inc. 1,047,000$4,837,0002.18%
Sarissa Capital Management LP 4,299,297$19,863,0002.00%
Decheng Capital Management III (Cayman), LLC 904,268$4,178,0001.58%
SILVERARC CAPITAL MANAGEMENT, LLC 850,000$3,927,0001.21%
Orbimed Advisors 9,011,437$41,633,0000.75%
Avoro Capital Advisors LLC 7,550,000$34,881,0000.69%
Rock Springs Capital Management LP 4,075,958$18,831,0000.55%
Artal Group S.A. 2,200,000$10,164,0000.54%
DAFNA Capital Management LLC 406,763$1,879,0000.51%
View complete list of MERSANA THERAPEUTICS INC shareholders